News & Trends - Pharmaceuticals
Janssen appoints former Bayer talent as new Senior Manager of Communications & Public Affairs
Pharma News: Former Bayer talent has joined Janssen ANZ as Senior Manager, Communications & Public Affairs.
Michelle D’Heureux joins Janssen after four years at Bayer, where she most recently served as the Head of Communications, Health. With deep ties throughout the Australian & New Zealand pharmaceutical sector, Michelle also previously worked in senior communications roles at Novartis, Eli Lilly and Baxter Healthcare.
Janssen ANZ Head of Communications and Public Affairs, Adam Wyldeck said he was thrilled that Michelle was joining his team.
“I am delighted that Michelle has decided to join Janssen. She brings a wealth of experience and knowledge to the company at a time when communications is playing an increasingly critical role for the business.
“Communications and public affairs is changing, the way we interact with our stakeholders is evolving.”
Michelle told Health Industry Hub “Janssen is a highly respected industry leader with a trusted heritage in healthcare. I’m excited to be part of the team and I look forward to connecting with colleagues across the business to deliver initiatives that drive access and improve patient outcomes.”
You may also like: Novartis, the only pharma company, recognised as a DCA Inclusive Employer
The appointment leads a restructuring of Janssen ANZ’s communications team that will see the appointment of new talent and skills to meet the rapidly changing communications landscape and deliver on the organisation’s ambitious growth outcomes.
Michelle will lead communication activities across multiple therapeutic areas within the Janssen ANZ business, drawing on her considerable experience driving high profile PBS and Pharmac listings and the development of strategic communication plans spanning neuroscience, oncology, ophthalmology and more.
Michelle holds a Bachelor of Arts, Communication Studies from the University of Western Sydney with majors in Public Relations and Health Communication.
News & Trends - Biotechnology
AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm
Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]
MoreNews & Trends - MedTech & Diagnostics
Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis
MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]
MoreNews & Trends - MedTech & Diagnostics
Cardiac device benefits face more cuts, while technical services remain secure in the short term
MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]
MoreNews & Trends - Biotechnology
CSL’s world-first gene therapy heads for MSAC evaluation
Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]
More